Prot# KAN-979-02: An Open-Label, Phase I/II Trial of Gemtuzumab Ozogamicin (GO) in Combination with Zosuquidar in Patients Age 55-75 Years with CD33 Positive Acute Myeloid Leukemia in First Relapse

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/11/06 → 11/21/11

Funding

  • Kanisa Pharmaceuticals, Inc. (KAN-979-02)